https://doctransparency.com/doctor/fl/boca-raton/stuart-isaacson-1023059169
Medicare Enrolled

Dr. Stuart Isaacson, MD

Neurology · Boca Raton, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
951 NW 13TH ST, Boca Raton, FL 33486
5613921818
In practice since 2006 (19 years)
NPI: 1023059169 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Isaacson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Isaacson? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Isaacson

Dr. Stuart Isaacson is a neurology in Boca Raton, FL, with 19 years in practice. Based on federal Medicare data, Dr. Isaacson performed 7,899 Medicare services across 584 unique beneficiaries.

Between the years covered by Open Payments, Dr. Isaacson received a total of $4,003,078 from 50 pharmaceutical and/or device companies across 3424 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Isaacson is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 13% volume in FL$ $4,003,078 industry payments

Medicare Practice Summary

Medicare Utilization ↗
7,899
Medicare services
Top 13% in FL for neurology
584
Unique beneficiaries
$20
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~416 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Botox injection, per unit4,600$5$7
Botox injection (Xeomin), per unit2,200$4$5
Office visit, established patient, complex (40-54 min)431$143$185
Telephone medical discussion with physician, 21-30 minutes294$101$131
Office visit, established patient (30-39 min)205$98$132
Telephone medical discussion with physician, 11-20 minutes47$70$94
Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box29$174$222
Punch biopsy, each additional skin growth27$48$61
Injection of chemical for paralysis of salivary glands on both sides of mouth27$112$142
Punch biopsy, first skin growth15$102$130
Office visit, established patient (20-29 min)13$73$94
New patient office visit, complex (60-74 min)11$173$229
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,003,078
Total received (2018-2024)
Avg $571,868/year across 7 years
Top 0% in FL for neurology
50
Companies
3,424
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,282,627 (82.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$670,518 (16.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$49,934 (1.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$537,093
2023
$487,401
2022
$486,329
2021
$582,150
2020
$495,392
2019
$782,978
2018
$631,735

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ACADIA Pharmaceuticals Inc
$638,664
Teva Pharmaceuticals USA, Inc.
$500,988
MDD US Operations, LLC
$410,287
Neurocrine Biosciences, Inc.
$401,771
Kyowa Kirin, Inc.
$335,792
US WorldMeds, LLC
$263,459
Acorda Therapeutics, Inc
$261,259
Amneal Pharmaceuticals LLC
$254,571
Sunovion Pharmaceuticals Inc.
$234,897
Adamas Pharmaceuticals, Inc.
$208,591
Lundbeck LLC
$76,950
ABBVIE INC.
$71,402
Neurocrine BioSciences, Inc.
$66,515
H. Lundbeck A S
$31,046
Allergan Inc.
$30,623
Kyowa Hakko Kirin Co., Ltd
$30,281
Sumitomo Pharma America, Inc.
$28,250
Allergan, Inc.
$25,981
Impax Laboratories, Inc.
$24,791
Merz Pharmaceuticals, LLC
$22,598
AbbVie, Inc.
$22,178
Cala Health, Inc.
$11,284
GE Healthcare
$7,151
AbbVie Inc.
$6,678
Kyowa Kirin Services Ltd
$6,000
Kyowa Kirin Co., Ltd
$5,625
Genentech, Inc.
$4,590
MITSUBISHI TANABE PHARMA AMERICA, INC.
$4,462
UCB, Inc.
$3,806
JAZZ PHARMACEUTICALS INC.
$3,780
Supernus Pharmaceuticals, Inc.
$3,227
Global Kinetics USA Corporation
$1,500
GENZYME CORPORATION
$900
Avion Pharmaceuticals
$596
Sage Therapeutics, Inc.
$551
Vertex Pharmaceuticals Incorporated
$442
Abbott Laboratories
$441
Ipsen Biopharmaceuticals, Inc
$389
REVANCE THERAPEUTICS, INC.
$214
MERZ NORTH AMERICA, INC.
$186
Merz North America, Inc.
$96
Theravance Biopharma, Inc.
$58
Lilly USA, LLC
$45
Almatica Pharma LLC
$39
ARBOR PHARMACEUTICALS, INC.
$38
Azurity Pharmaceuticals, Inc.
$24
Avanir Pharmaceuticals, Inc.
$20
Vertical Pharmaceuticals, LLC
$18
InSightec,Inc
$15
Mitsubishi Tanabe Pharma America, Inc.
$13
Top 3 companies account for 38.7% of total payments
Associated products mentioned in payments ›
AJOVY · AMYVID · APL-130277 · APOKYN · AUSTEDO · Apokyn · Austedo XR · BOTOX · BOTOX THERAPEUTIC · CALA TRIO · CREXONT · DATSCAN · DAXXIFY · DISEASE EDUCATION · DUOPA · DYSPORT · Deep Brain Stimulation · Dhivy · Duopa · Dysport · Edarbi · Exablate · GOCOVRI · GRALISE · Gocovri · HORIZANT · Horizant · INBRIJA · INFINITY · INGREZZA · ISTRADEFYLLINE · Infinity DBS Pulse Generators · KISUNLA · KYNMOBI · LATUDA · LONHALA MAGNAIR · MYOBLOC · NAMZARIC · NO PRODUCT DISCUSSED · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · Neupro · Nourianz · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · OSMOLEX ER · Ongentys · Qelbree · RASAGILINE · RYTARY · SUVECALTAMIDE · UBRELVY · VYALEV · XADAGO · XEOMIN · Xadago · Xeomin
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (82%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for neurology in FL.

Equivalent to $50,678 per 100 Medicare services performed
Looking for a neurology in Boca Raton?
Compare neurologys in the Boca Raton area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
148
Per 100K population
9.8
County median income
$81,115
Nearest hospital
BOCA RATON REGIONAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Isaacson is a mixed practice specialist, with above-average Medicare volume (top 13% in FL), and high industry engagement (speaking/promotional, top 0%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Isaacson experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Isaacson performed 4,600 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Isaacson receive payments from pharmaceutical companies?
Yes. Dr. Isaacson received a total of $4,003,078 from 50 companies across 3,424 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Isaacson's costs compare to other neurologys in Boca Raton?
Dr. Isaacson's average Medicare payment per service is $20. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Isaacson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →